Reference | <br />
1:SB-431542, a specific inhibitor of the TGF-β type I receptor inhibits hypoxia-induced proliferation of pulmonary artery adventitial fibroblasts. Yuan W, Liu W, Cai H, Sun X, Yang D, Xu F, Jin C.Pharmazie. 2016 Feb;71(2):94-100. PMID: 27004374<br />
2:Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity. Tanaka H, Shinto O, Yashiro M, Yamazoe S, Iwauchi T, Muguruma K, Kubo N, Ohira M, Hirakawa K.Oncol Rep. 2010 Dec;24(6):1637-43. PMID: 21042762<br />
3:Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. Mahmood A, Harkness L, Schrøder HD, Abdallah BM, Kassem M.J Bone Miner Res. 2010 Jun;25(6):1216-33. doi: 10.1002/jbmr.34. PMID: 20200949 Free Article<br />
4:SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Xiao YQ, Liu K, Shen JF, Xu GT, Ye W.Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1698-706. doi: 10.1167/iovs.08-1675. Epub 2008 Dec 20. PMID: 19098325<br />
5:SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion. Waghabi MC, Keramidas M, Calvet CM, Meuser M, de Nazaré C Soeiro M, Mendonça-Lima L, Araújo-Jorge TC, Feige JJ, Bailly S.Antimicrob Agents Chemother. 2007 Aug;51(8):2905-10. Epub 2007 May 25. PMID: 17526757 Free PMC Article<br />
6:SB-431542 inhibits TGF-beta-induced contraction of collagen gel by normal and keloid fibroblasts. Hasegawa T, Nakao A, Sumiyoshi K, Tsuchihashi H, Ogawa H.J Dermatol Sci. 2005 Jul;39(1):33-8. PMID: 15978417<br />
7:A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Halder SK, Beauchamp RD, Datta PK.Neoplasia. 2005 May;7(5):509-21. PMID: 15967103 Free PMC Article<br />
8:SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, Laping NJ, Friedman HS, Bigner DD, Wang XF, Rich JN.Mol Cancer Ther. 2004 Jun;3(6):737-45. PMID: 15210860 Free Article<br />
9:SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. Matsuyama S, Iwadate M, Kondo M, Saitoh M, Hanyu A, Shimizu K, Aburatani H, Mishima HK, Imamura T, Miyazono K, Miyazawa K.Cancer Res. 2003 Nov 15;63(22):7791-8. PMID: 14633705 Free Article<br />
10:SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS.Mol Pharmacol. 2002 Jul;62(1):65-74. PMID: 12065756 Free Article
|